Risk of combination of tri-acetyl-oleandomycin and ergotamine tartrate.
D000328:Adult; D004359:Drug Therapy, Combination / Q000009:adverse effects*; D004878:Ergotamine / Q000009:adverse effects*; D004881:Ergotism / Q000139:chemically induced*; D005260:Female; D006801:Humans; D007511:Ischemia / Q000139:chemically induced; D007866:Leg / Q000098:blood supply; D014217:Troleandomycin / Q000009:adverse effects*
D014217:Troleandomycin; D004878:Ergotamine
Les riques de l'association tri-acétyl-oléan-domycine et tartrate d'ergotamine